DAPTACEL

Sanofi Vaccines US Inc.🇺🇸 United States

FDA Page

Effective Date: Sep 2, 2026
Approval ID: 06f34d0f-4e72-41d3-967f-8abf3f2005c1
Products: 1 registered
Version: 18

Regulatory Information

Labeling Type

VACCINE LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DAPTACEL safely and effectively. See full prescribing information for DAPTACEL. DAPTACEL (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) injectable suspension, for intramuscular useInitial U.S. Approval: 2002

Quick Stats

Total Products1

Labelers1

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.